-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HpW0rVTzbD8IwV6Cs7V8LZVCkXo84+ZXrBc5has/IjTttwM0lP2E3AdRx7qdVC8m T7WB54g4T5Jjc9gcZp6/dw== 0000950142-04-002755.txt : 20040730 0000950142-04-002755.hdr.sgml : 20040730 20040730161425 ACCESSION NUMBER: 0000950142-04-002755 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040728 FILED AS OF DATE: 20040730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AUXILIUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001182129 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] BUSINESS ADDRESS: STREET 1: 160 WEST GERMANTOWN PIKE STREET 2: SUITE D-5 CITY: NORRISTOWN STATE: PA ZIP: 19401 BUSINESS PHONE: 610-239-8850 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOROS FUND MANAGEMENT LLC CENTRAL INDEX KEY: 0001029160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50855 FILM NUMBER: 04942536 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 2128721054 MAIL ADDRESS: STREET 1: C/O AKIN, GUMP, STRAUSS,HAUER,FELD, STREET 2: 399 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOROS GEORGE CENTRAL INDEX KEY: 0000900203 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50855 FILM NUMBER: 04942535 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 212-262--6 MAIL ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 33RD FLR CITY: NEW YORK STATE: NY ZIP: 10106 4 1 form4-sfm072804_auxlex.xml FORM 4 X0202 4 2004-07-28 0 0001182129 AUXILIUM PHARMACEUTICALS INC AUXL 0001029160 SOROS FUND MANAGEMENT LLC 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 0 0 1 0 0000900203 SOROS GEORGE 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 0 0 1 0 Common Stock 2004-07-28 4 C 0 2080000 A 2162793 I See footnotes Common Stock 2004-07-28 4 C 0 546666 A 2709459 I See footnotes Common Stock 2004-07-28 4 C 0 505855 A 3215314 I See footnotes Common Stock 2004-07-28 4 P 0 50000 7.50 A 3265314 I See footnotes Series B Convertible Preferred Stock 2004-07-28 4 C 0 10400000 A Common Stock 2080000 0 I See footnotes Series C Convertible Preferred Stock 2004-07-28 4 C 0 2733334 A Common Stock 546666 0 I See footnotes Series D Convertible Preferred Stock 2004-07-28 4 C 0 2529729 A Common Stock 505855 0 I See footnotes Each outstanding share of the Issuer's Series B Convertible Preferred Stock automatically converted into .2 shares of common stock immediately prior to the Issuer's initial public offering. Each outstanding share of the Issuer's Series C Convertible Preferred Stock automatically converted into .2 shares of common stock immediately prior to the Issuer's initial public offering. Each outstanding share of the Issuer's Series D Convertible Preferred Stock automatically converted into .2 shares of common stock immediately prior to the Issuer's initial public offering. These securities are held for the account of Perseus-Soros BioPharmaceutical Fund, LP ("Perseus-Soros"). Perseus-Soros Partners, LLC, a Delaware limited liability company ("Perseus-Soros Partners"), is the general partner of Perseus-Soros. Perseus BioTech Fund Partners, LLC, a Delaware limited liability company ("Perseus Partners"), and SFM Participation, L.P., a Delaware limited partnership ("SFM Participation"), are the managing members of Perseus-Soros Partners. SFM AH LLC, a Delaware limited liability company ("SFM AH"), is the general partner of SFM Participation. The sole managing member of SFM AH is Soros Fund Management LLC, a Delaware limited liability company ("SFM LLC"). Mr. George Soros serves as Chairman of SFM LLC. Pursuant to Rule 16a-1(a)(2)(ii)(B) under the Securities Exchange Act of 1934, as amended (the "Act"), SFM LLC and Mr. Soros may be deemed to be the beneficial owners of the securities reported herein only to the extent of his or its pecuniary interest therein. Pursuant to Rule 16a-1(a)(4) under the Act, this filing shall not be deemed an admission that SFM LLC or Mr. Soros are, for purposes of Section 16 of the Act or otherwise, the beneficial owners of any securities reported herein in excess of such amount. /s/ Jodye M. Anzalotta, Assistant General Counsel 2004-07-30 /s/ Jodye M. Anzalotta, Attorney-in-Fact for George Soros 2004-07-30 -----END PRIVACY-ENHANCED MESSAGE-----